NCT06840717Recruiting
Association Between Genetic Polymorphisms and Type 2 Asthma in Children
Association Between Cytokines Gene Single Nucleotide Polymorphisms and Type 2 Inflammatory Asthma in Children
Source: ClinicalTrials.gov · Last updated 21 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To further understand the role of gene single nucleotide polymorphism (SNP) in the occurrence of type 2 inflammation-related asthma in children by analyzing the gene single nucleotide polymorphism (SNP), lung function and type 2 inflammation indicators of children diagnosed with asthma in outpatient and inpatient. To provide a theoretical basis for the study of personalized treatment and prevention strategies for asthma.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 3 Oct 2024
- Start date
- 30 Jan 2024
- Primary completion date
- 30 Dec 2025
- Lead sponsor
- Guangzhou Institute of Respiratory Disease
- Diseases
- Asthma
- NCT number
- NCT06840717
What you commit to
- Study type: Observational
- Planned participants: 300
- From 30 Jan 2024 to the primary completion date, 30 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Children who had taken immunosuppressants, antibiotics and other drugs for a long time before admission;
Other illness
- Children with primary immunodeficiency disease;
Other
- The children and their families failed to cooperate or refused the experimental observation.
Who the study is looking for
- All children with asthma diagnosis accord with the GINA in 2023 edition;
- Other diseases that could cause wheezing and cough were excluded, such as acute laryngitis, diphtheria, congenital airway abnormalities, and tracheal foreign bodies;
- In front of the hospital 2 weeks without antibiotics, systemic hormone medication history;
- There were no other complications, such as congenital heart disease, pneumonia, gastroesophageal reflux disease, muscle dysplasia, etc.
Age in the registry: 3 years to 14 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Guangzhou Institute of Respiratory Disease Coordinator of this site? Confirm its status | Guangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.